Evidence map›Paper›PMID 30621089›Full record

ArticleMaterials (Basel, Switzerland)2019

Increasing Uptake of Silica Nanoparticles with Electroporation: From Cellular Characterization to Potential Applications.

Erick Phonesouk, Séverine Lechevallier, Audrey Ferrand, Marie-Pierre Rols, Christine Bezombes, Marc Verelst, Muriel Golzio

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Use of Protamine in Nanopharmaceuticals-A Review.Nanomaterials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erick PhonesoukInstitut de Pharmacologie et de Biologie Structurale-UMR 5089, 205 route de Narbonne, 31077 Toulouse CEDEX 04, France. Erick_31@hotmail.fr.
Séverine LechevallierChromalys SAS, 29 rue jeanne Marvig, 31400 Toulouse, France. severine.lechevallier@chromalys.fr.
Audrey FerrandIRSD, Université de Toulouse, INSERM (U1220), INRA, ENVT, UPS, 31024Toulouse cedex 3, France. audrey.ferrand@inserm.fr.ORCID 0000-0002-1057-8151
Marie-Pierre RolsInstitut de Pharmacologie et de Biologie Structurale-UMR 5089, 205 route de Narbonne, 31077 Toulouse CEDEX 04, France. rols@ipbs.fr.
Christine BezombesUMR1037 INSERM, Université de Toulouse, ERL5294 CNRS, 31100 Toulouse, France. christine.bezombes@inserm.fr.
Marc VerelstChromalys SAS, 29 rue jeanne Marvig, 31400 Toulouse, France. marc.verelst@chromalys.fr.
Muriel GolzioInstitut de Pharmacologie et de Biologie Structurale-UMR 5089, 205 route de Narbonne, 31077 Toulouse CEDEX 04, France. muriel.golzio@ipbs.fr.

Funding

Occitania region 30062015
6 · The paper itself

Abstract

In the fields of biology and medicine, nanoproducts such as nanoparticles (NPs) are specifically interesting as theranostic tools, since they offer the double capacity to locally deliver active drugs and to image exactly where the product is delivered. Among the many described possibilities, silica nanoparticles (SiNPs) represent a good choice because of their ease of synthesis, the possibility of their vast functionalization, and their good biocompatibility. However, SiNPs' passive cell internalization by endocytosis only distributes NPs into the cell cytoplasm and is unable to target the nucleus if SiNPs are larger than a few nanometers. In this study, we demonstrate that the cell penetration of SiNPs of 28⁻30 nm in diameter can be strongly enhanced using a physical method, called electroporation or electropermeabilization (EP). The uptake of fluorescently labelled silica nanoparticles was improved in two different cancer cell lines, namely, HCT-116 (human colon cancer) cells and RL (B-lymphoma) cells. First, we studied cells' capability for the regular passive uptake of SiNPs in vitro. Then, we set EP parameters in order to induce a more efficient and rapid cell loading, also comprising the nuclear compartment, while preserving the cell viability. In the final approach, we performed in vivo experiments, and evidenced that the labeling was long-lasting, as confirmed by fluorescence imaging of labeled tumors, which enabled a 30-day follow-up. This kind of SiNPs delivery, achieved by EP, could be employed to load extensive amounts of active ingredients into the cell nucleus, and concomitantly allow the monitoring of the long-term fate of nanoparticles.

Indexed as

drug deliveryelectric fieldelectroporationsilica nanoparticles fluorescence imagingtumor targeting

Identifiers

PMID30621089
PMCPMC6337455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.